ABVC BioPharma accepts additional $670K in Reg S offering, issuing 957,144 shares

ABVC BIOPHARMA, INC.

Initial Reg S offering (Apr 30–May 9) sold 1,030,413 shares for aggregate gross proceeds ~$619,625.
On May 27, accepted additional subscriptions of $670,000 for 957,144 shares on same terms as initial offering.
All shares sold to non-U.S. persons under Regulation S; voting rights transferred to chairman Eugene Jiang.
Combined gross proceeds from both tranches total ~$1.29 million; shares unregistered for one year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.